Develops drugs for women's health conditions, including contraception and menopause.
Jun 2026Revenue $1.37M/yrExpenses $12.5M/yr
No trendCash runway ≈ 1.1 years from Jun 2026
Figures by year
When will Dare Bioscience be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $1.37M and expenses $12.5M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $1.03M | $14.6M | −$13.6M |
| Dec 2024 | $9.78K | $23.5M | −$23.5M |
| Dec 2023 | $2.81M | $33.7M | −$30.9M |
| Dec 2022 | $10.0M | $41.4M | −$31.4M |
| Dec 2021 | $0.00 | $39.1M | −$39.1M |
| Dec 2016 | $766K | $1.40M | −$631K |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.